PharmiWeb.com - Global Pharma News & Resources
18-Feb-2019

Point-Of-Care Infectious Disease Diagnostics Market|Healthy Growth in 2019 Annual Results

Infectious diseases are generally a result of infection in an individual. Infectious disease diagnostics is the process of identifying presence of foreign antigen/organisms with the help of various diagnostic tools. Infectious diseases are generally spread through microorganisms such as parasites, fungi, and bacteria. It can also spread from one person to another, directly or indirectly. Point-of-care infectious disease diagnostic facilities are places wherein an individual can get proper diagnosis and treatment (up to a certain extent) without him/her having to visit a hospital or medical center.

Increasing incidence of infectious diseases coupled with technological advancements in point-of-care diagnostic facilities are major factors driving growth of the global point-of-care disease diagnostics market. Additionally, increasing government initiatives for spreading awareness about infectious diseases and treatments, coupled with increasing support by the governments for development of proper healthcare facilities, especially in emerging economies are other major factors expected to propel growth of the global market over the forecast period. But, high costs coupled with lack of skilled professionals at point-of-care facilities are major factors hampering growth of the global market.

The global point-of-care infectious disease diagnostics market report has been segmented on the basis of product, mode of prescription, end user, and region. On the basis of region, the global point-of-care infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Global point-of-care infectious disease diagnostics market segmentation:

By product:

  • Glucose monitoring kits
  • Infectious disease testing kits
  • Pregnancy and fertility testing kits
  • Hematology testing kits
  • Cardio metabolic monitoring kits
  • Urinalysis Testing Kits
  • Coagulation Monitoring Kits
  • Tumor/Cancer Markers Testing Kits
  • Drugs of Abuse Testing Kits
  • Others (Calcium Assay Kits, Cholesterol Test Strips, Fecal Occult Testing Kits and Immunochemistry Kits)

By mode of prescription:

  • Prescription based point of care diagnostics
  • Over-the-counter (OTC) based point of care testing devices

By end user:

  • Professional Diagnostic Centers
  • Research Laboratories
  • Home Care
  • Others

Get Free Sample Copy Of This Research @ https://marketresearch.biz/report/point-of-care-infectious-disease-diagnostics-market/request-sample/

The market in North America accounted for highest share in terms of revenue in the global market, and is projected to maintain its dominance over the forecast period. This can be attributed to high prevalence of infectious diseases, high awareness among individuals about infectious disease diagnostics, and presence of proper point-of-care infectious disease diagnostic facilities in countries in the region. Revenue from the market in Asia Pacific accounted for second-highest share in revenue terms, and is projected to register highest CAGR over the forecast period. This is attributed to increasing government initiatives for development of proper healthcare facilities coupled with initiatives for spreading awareness about infectious diseases and treatment in emerging economies such as China and India. Also, the markets in Europe, Latin America, and Middle East & Africa are projected to witness moderate growth over the forecast period.

Prominent players in the global point-of-care infectious disease diagnostics market include Abbott Laboratories, Siemens AG, F. Hoffmann-La Roche Ltd., Sinocare Inc., Johnson & Johnson, Sysmex Corporation, Nova Biomedical, Danaher Corporation, Becton Dickinson and Company, bioMrieux SA, and Bio-Rad Laboratories.

Editor Details

Last Updated: 18-Feb-2019